| The Anal Pap: A guide for primary care providers |
| BIBLIOGRAPHY [1]Palefsky JM, Cranston RD. Anal squamous intraepithelial lesions (ASIL): Diagnosis, screening and treatment. UpToDate, online version 9.2. [2]Daling JR, Weiss NS, Hislop TG, et al. Sexual practices, sexually transmitted disease, and the incidence of anal cancer. N Engl J Med 1987; 317: 973-7. [3]Palefsky JM, Holly EA, Hogeboom CJ, et al. Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17: 314-319. [4] Palefsky JM, Cranston RD. Virology of human papillomavirus infections and the link to cancer. UpToDate, online version 9.2. [5] Vernon SD, Hart CE, Reeves WC, Icenogle JP. The HIV-1 tat protein enhances E-2 dependent human papillomavirus 16 transcription. Virus Res 1993; 27:133. [6]Palefsky JM, Berry JM. Pathogenesis and clinical manifestations of HIV-associated anogenital neoplasia. Web Site: The AIDS Knowledge Base. November 1998. [7] Palefsky JM, Holly EA, Ralston ML, et al. High incidence of anal high-grade squamous intraepithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men. AIDS 1998; 12:495-503. [8] Frisch M, Bengt G, et al. Sexually transmitted infection as cause of anal cancer. N Engl J Med 1997; 337:19:1350-1358. [9] Holly EA, Ralston ML, Darragh TM et al. Prevalence and risk factors for anal squamous intraepithelial lesions in women. Journal of Nat Cancer Inst 2001:93:11:843-849. [10]Friis S, Kjaer SK, Frisch M et al. Cervical intraepithelial neoplasia, anogenital cancer, and other cancer types in women after hospitalization for Condyloma Acuminata. Journal Infect Disease 1997; 175:743-8. [11]Ryan DP, Compton CC, Mayer RJ. Carcinoma of the anal canal. N Engl J Med 2000; 342:11:792-800. [12]Penn, I. Cancer of the anogenital region in renal transplant recipients. Cancer 1986; 58: 611-616. [13]Martins, CR. HPV-induced anal dysplasia: What do we know and what can we do about it? The Hopkins HIV Report. May 2001. [14]Darragh TM, Jay N, et al. Comparison of conventional cytologic smears and ThinPrep preparations from the anal canal. Acta Cytologica 1997; 41:4:1167-1170. [15]Palefsky JM, Holly EA, Hogeboom CJ, et al. Anal cytology as a screening tool for anal squamous intraepithelial lesions. J Acquir Immune Defic Syndr Hum Retrovirol 1997: 14: 415-422. [16]Goldie SJ, Kuntz KM, Weinstein MC, et al. The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA 1999: 281: 1822-1829. [17]Goldie SJ, Kuntz KM, Weinstein MC, et al. The cost-effectiveness of screening for anal squamous intraepithelial lesions in HIV-negative homosexual and bisexual men. Am J Med 2000; 108:634-641. |
| CONTENTS: |
| Bibliography |
| The Anal Pap: A guide for primary care providers |
| Demetre Daskalakis, MD |